Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 31% ± 14% | |
peripheral blood | 9 studies | 24% ± 6% | |
kidney | 9 studies | 33% ± 8% | |
intestine | 8 studies | 27% ± 11% | |
brain | 6 studies | 26% ± 7% | |
bone marrow | 5 studies | 20% ± 5% | |
liver | 5 studies | 37% ± 22% | |
pancreas | 3 studies | 58% ± 14% | |
placenta | 3 studies | 35% ± 18% | |
eye | 3 studies | 25% ± 8% | |
adrenal gland | 3 studies | 29% ± 11% | |
thymus | 3 studies | 41% ± 12% | |
breast | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6408.68 | 1445 / 1445 | 100% | 118.86 | 183 / 183 |
ovary | 100% | 4377.41 | 180 / 180 | 100% | 166.79 | 430 / 430 |
prostate | 100% | 5619.90 | 245 / 245 | 100% | 184.54 | 501 / 502 |
stomach | 100% | 5096.12 | 359 / 359 | 100% | 154.87 | 285 / 286 |
breast | 100% | 6451.12 | 459 / 459 | 100% | 183.93 | 1114 / 1118 |
intestine | 100% | 6986.51 | 966 / 966 | 100% | 152.52 | 525 / 527 |
thymus | 100% | 7553.04 | 653 / 653 | 100% | 167.99 | 602 / 605 |
brain | 100% | 5141.66 | 2630 / 2642 | 100% | 109.99 | 704 / 705 |
kidney | 100% | 11171.78 | 89 / 89 | 99% | 163.22 | 895 / 901 |
lung | 99% | 4420.76 | 573 / 578 | 100% | 135.97 | 1155 / 1155 |
liver | 100% | 11951.86 | 226 / 226 | 99% | 175.00 | 402 / 406 |
adrenal gland | 100% | 23390.05 | 258 / 258 | 99% | 179.13 | 227 / 230 |
bladder | 100% | 6304.00 | 21 / 21 | 98% | 126.65 | 496 / 504 |
uterus | 100% | 5464.80 | 170 / 170 | 98% | 114.33 | 451 / 459 |
pancreas | 99% | 2973.39 | 324 / 328 | 99% | 100.58 | 177 / 178 |
skin | 97% | 5042.08 | 1761 / 1809 | 96% | 101.68 | 453 / 472 |
adipose | 100% | 6702.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 124.89 | 29 / 29 |
muscle | 100% | 13155.19 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4817.22 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 57.53 | 1 / 1 |
blood vessel | 100% | 6123.60 | 1333 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 87.79 | 44 / 45 |
heart | 95% | 8361.36 | 822 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 75.29 | 72 / 80 |
peripheral blood | 72% | 4578.44 | 673 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0042542 | Biological process | response to hydrogen peroxide |
GO_0001893 | Biological process | maternal placenta development |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0033554 | Biological process | cellular response to stress |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0042744 | Biological process | hydrogen peroxide catabolic process |
GO_0051881 | Biological process | regulation of mitochondrial membrane potential |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0033673 | Biological process | negative regulation of kinase activity |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0007005 | Biological process | mitochondrion organization |
GO_0018171 | Biological process | peptidyl-cysteine oxidation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030099 | Biological process | myeloid cell differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006979 | Biological process | response to oxidative stress |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0043027 | Molecular function | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO_0008379 | Molecular function | thioredoxin peroxidase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0008785 | Molecular function | alkyl hydroperoxide reductase activity |
Gene name | PRDX3 |
Protein name | Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 3) Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3) |
Synonyms | hCG_37898 AOP1 |
Description | FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides . Acts synergistically with MAP3K13 to regulate the activation of NF-kappa-B in the cytosol . Required for the maintenance of physical strength (By similarity). . |
Accessions | A0A384MTR2 ENST00000298510.4 [P30048-1] P30048 |